Lactate gavage improved survival trends and increased intestinal length in CLP mice.
Histopathological analysis showed increased villus length in lactate-treated CLP mice.
Interpretation:
Lactate may be essential for intestinal epithelial cell renewal during sepsis, suggesting a potential therapeutic role in managing sepsis-related intestinal injury.
Limitations:
Lactate administration was non-cell-specific, complicating the understanding of its mechanism.
The study did not assess the effects of lactate on sham mice, leaving its impact on non-septic conditions unknown.
Conclusion:
Intestinal lactate may protect against sepsis-induced damage and could be a promising therapeutic strategy for critically ill patients.
